Side effects of Petibelle in details
The following is a list of the side effects that have been linked with the use of Petibelle: Common (between 1-10 in every 100 users may be affected): Mood swings, headache, nausea, breast pain, problem with periods eg, irregular menstruations and absence of periods.
Uncommon (between 1-10 in every 1000 users may be affected): Depression, loss of interest in sex, nervousness, sleepiness; dizziness, "pins and needles"; migraine, varicose veins, increased blood pressure; stomach ache, vomiting, indigestion, intestinal gas, inflammation of the stomach, diarrhea; acne, itching, rash; aches and pains eg, back pain, limb pain, muscular cramps; vaginal fungal infection, pelvic pain, breast enlargement, benign breast lumps, uterine/vaginal bleeding (which usually subsides during continued treatment), genital discharge, hot flushes, inflammation of the vagina (vaginitis), problems with periods; painful, reduced and very heavy periods; vaginal dryness, abnormal cervical smear; lack of energy, increased sweating, fluid retention, increased weight.
Rare (between 1-10 in every 10,000 users may be affected): Candida (fungal infection), anemia, increased number of platelets in the blood, allergic reaction, hormonal (endocrine) disorder; increased appetite, loss of appetite, abnormally high concentration of potassium in the blood, abnormally low concentration of sodium in the blood; failure to experience an orgasm, insomnia; giddiness, tremor; eye disorders eg, inflammation of the eyelid, dry eyes; abnormally rapid heartbeat, inflammation of a vein, nosebleed, fainting; enlarged abdomen, bowel disorder, feeling bloated, stomach hernia, fungal infection of the mouth, constipation, dry mouth; pain of bile ducts or gallbladder, inflammation of gallbladder; yellow-brown patches on the skin, eczema, hair loss; lumpy, light-sensitive and acne-like skin inflammation; dry skin, excessive hair growth, skin disorder, stretch marks on the skin, skin inflammation, skin nodules; difficult or painful sex, vaginal inflammation (vulvovaginitis), bleeding following intercourse, withdrawal bleeding, breast cyst, increased number of breast cells (hyperplasia), malignant breast lumps, abnormal growth on the mucosal surface of the neck of the womb, shrinkage or wasting of the lining of the womb, ovarian cysts, womb enlargement, feeling generally unwell, weight loss.
The following adverse effects have also been reported, but their frequency cannot be estimated from the available data: Hypersensitivity, erythema multiforme (rash with target-shaped reddening or sores).
If any of the adverse effects get serious, or if any side effects not listed is noticed, inform a physician or pharmacist.
Petibelle contraindications
Hypersensitivity to Drospirenone (Petibelle) or Ethinylestradiol (Petibelle) or any other ingredient in Petibelle. This could cause itching, a rash or inflammation.
Patients that have (or have had in the past) blood clots (thrombosis) in a blood vessel of the leg, lungs (embolsim) or other organs; a heart attack or stroke; any illness which could lead to a heart attack (eg, angina pectoris which causes serious pain in the chest) or a stroke (eg, a temporary or minor stroke without residual effects); certain form of migraine (focal neurological symptoms); inflammation of the pancreas (pancreatitis); liver illness and hepatic function have not yet normalized; kidneys do not work well (kidney failure); liver tumor; suspect breast cancer or cancer of the sexual organs.
Any illness which could increase the risk of developing artery thrombosis eg, diabetes with damaged blood vessels, very high blood pressure, very high fat levels in the blood (cholesterol or triglycerides); disturbance of blood clotting (eg, protein C deficiency); vaginal bleeding and the cause is unknown.
Use in pregnancy: If the patient is pregnant, do not take Petibelle. If the patient is pregnant when taking Petibelle, stop taking it immediately and contact the doctor.
Consult the doctor or pharmacist before taking any medicine.
References
- DailyMed. "DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- European Chemicals Agency - ECHA. "Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(5'H)-furan]-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, [6R-(6α,7α,8β,9α,10β,13β,14α,15α,16α,17β)]-: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
- HSDB. "Drospirenone". https://toxnet.nlm.nih.gov/cgi-bin/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Petibelle are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Petibelle. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported side effects
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
